NYU Langone Health is a world-class integrated academic health system and one of the largest in the Northeast—stretching across 7 inpatient facilities and over 320 locations throughout the New York City region and in Florida. Our more than 53,000 staff members, led by Dean and CEO Alec C. Kimmelman, MD, PhD, provide life-changing care, innovative medical education, and groundbreaking advances in research, always guided by our purpose to deliver the best outcomes in patient care, education, and science.
Our Leadership, Campus Transformation, and Community Service PlanOur mission—to care, to teach, to discover—is achieved daily through a culture of exceptionalism. Our values of performance, respect, integrity, diversity, and excellence (PRIDE) influence the way we show up each day for our patients, our students, and our communities.
In 2024, NYU Langone Health’s revenue was $14.2 billion, including more than $5.5 billion in philanthropy since 2007.
NYU Langone has been consistently ranked as one of the top integrated academic health systems in the nation. Vizient Inc. has recognized NYU Langone as No. 1 for quality care in the United States for the fourth year in a row, and the No. 1 physician practice network in the United States for 10 of the last 12 years. In addition, NYU Langone Health has more No. 1-ranked specialties than any other health system in the United States, according to U.S. News & World Report, which named our system best in the nation for neurology and neurosurgery (for the fourth straight year); cardiology, heart, and vascular surgery; pulmonology and lung surgery; and geriatrics. We were also included on its “Best Hospitals” Honor Roll of the top 20 hospitals in the nation and among the No. 1 hospitals in the New York metro area. Our hospitals in Manhattan and Brooklyn and on Long Island have received straight A’s for safety from The Leapfrog Group, a national nonprofit organization that monitors healthcare safety and quality. Only 4 percent of graded hospitals nationwide have earned 10 consecutive “A” ratings, underscoring our commitment to keeping patients safe and providing the best outcomes.
Because of our commitment to continuous improvement and delivering safe, high-quality care, we have received The Gold Seal of Approval® by The Joint Commission. The Centers for Medicare and Medicaid Services has awarded NYU Langone a five-star rating for quality. We are the only health system—that is, a multispecialty and multisite hospital organization—in New York to receive Magnet® Recognition across all our hospitals for excellence in nursing and quality patient care from the American Nurses Credentialing Center, an honor achieved by only 10 percent of hospitals in the United States. The foundation of these consistently high rankings and prestigious honors were built during the tenure of former CEO and Dean , who oversaw the transformation of NYU Langone into a nationally-lauded engine for clinical, educational, and research innovation.
NYU Langone’s positive impact on the community goes well beyond patient care. As part of our commitment to delivering the best outcomes, we ensure that all individuals—regardless of background, zip code, or ability to pay—have access to world-class healthcare. We are dedicated to advancing health equity in the communities we serve by addressing the social determinants of health that most significantly affect our patients to help create more equitable outcomes for all. In the fiscal year ending August 31, 2023, our total community benefit contribution was $2.7 billion—more than 22 percent of our total expenditures. Notably, over 74 percent of that amount reflects the cost of providing charity care and underfunded care.
We partner with city, state, and federal officials, community boards, and local organizations to foster relationships that strengthen neighborhoods. Our outreach efforts span all five boroughs and beyond, aiming to raise awareness of NYU Langone’s resources and services while addressing the needs of diverse populations. Through sponsorships and collaborations, we support a wide range of community-based organizations, nonprofits, and local events—from health fairs and cultural celebrations to educational seminars and family programs. These partnerships are at the heart of our community engagement strategy and reflect our deep commitment.
NYU Langone was founded as the Medical College of New York University in 1841 by Valentine Mott, MD, the premier surgeon of his day, and five other eminent physicians and scientists. NYU Langone’s first hospital, known as University Hospital, was established in 1948, a century after its Medical College. In 1963, a newly acquired site in midtown Manhattan became the home of University Hospital’s new 18-story building. Adopting a novel concept in healthcare, the acute-care facility—now Tisch Hospital—partnered with outpatient practices to speed the translation of scientific discovery to the clinic and allow physicians to conduct academic and research activities while maintaining private practice.
The first hospital to merge with our institution was the Hospital for Joint Diseases, now known as NYU Langone Orthopedic Hospital. The 225-bed hospital, a longtime affiliate, became NYU Langone’s dedicated orthopedic hospital in 2006. In 2018, a new Science Building, NYU Langone’s largest research facility, united teams of investigators previously housed in several facilities. That same year, the Helen L. and Martin S. Kimmel Pavilion opened and became the only inpatient facility in New York City with exclusively private rooms. Kimmel Pavilion also includes Hassenfeld Children’s Hospital at NYU Langone, the city’s first new children’s hospital in nearly 15 years. Combined, Tisch Hospital, Kimmel Pavilion, and Hassenfeld Children’s Hospital have 813 beds.
In 2016, we acquired Lutheran Medical Center, a 444-bed acute-care hospital in southwest Brooklyn. Within several years, NYU Langone Hospital—Brooklyn, as it was renamed, benefited so greatly from our health system’s infusion of resources and expertise that it now qualifies as one of the safest hospitals, not only in New York City, but also in the nation. The only five-star hospital in Brooklyn, as ranked by CMS, NYU Langone Hospital—Brooklyn is the first and only hospital in Brooklyn to receive Magnet recognition for excellence in nursing and quality patient care.
In 2019, NYU Langone extended its reach once again, this time to Nassau County on Long Island. Our acquisition of Winthrop University Hospital, a 591-bed acute-care hospital in Mineola, enlarged the NYU Langone system by 25 percent. Thanks to the same rigorous quality control measures implemented at our Brooklyn hospital, NYU Langone Hospital—Long Island, as it was renamed, saw its average length of stay, a key measure of patient safety, decrease by nearly 20 percent in just two years.
To further strengthen NYU Langone’s presence on Long Island, in March 2025, NYU Langone merged with Long Island Community Hospital to create NYU Langone Hospital—Suffolk. This 306-bed medical center is home to the Knapp Cardiac Care Center, an advanced facility for heart disease diagnosis and treatment, as well as a modern ambulatory surgical pavilion. It offers specialized services, including women’s imaging, a sleep laboratory, and bariatric surgery, and serves as the entry point for a Provisional Level 2 Trauma Center. The hospital is also designated by the New York State Department of Health as a Primary Stroke Center.
In 2025, continuing a tradition of exceptional healthcare leadership, Alec C. Kimmelman, MD, PhD, one of the nation’s preeminent radiation oncology researchers and physicians, became dean of NYU Grossman School of Medicine and CEO of NYU Langone Health.
In addition to providing our patients with the best quality and safety outcomes, our clinicians and researchers have set new standards for the diagnosis and treatment of diseases and have made or contributed to breakthroughs in biomedical science.
In 2015, a team of surgeons led by Eduardo D. Rodriguez, MD, DDS, Helen L. Kimmel Professor of Reconstructive Plastic Surgery and chair of NYU Langone’s , performed the most extensive face transplant to date, followed in 2020 by the world’s first successful face and double-hand transplant, and in 2023 by the world’s first whole-eye and partial-face transplant.
In 2021, a team of surgeons led by Robert Montgomery, MD, DPhil, director of the NYU Langone Transplant Institute, the H. Leon Pachter, MD, Professor of Surgery, and chair of the , performed the first investigational transplant of a kidney grown in a genetically altered pig to a brain-dead person whose bodily functions were sustained by mechanical support. In separate investigational procedures performed in June and July 2022, surgeons led by Dr. Montgomery successfully transplanted hearts from genetically altered pigs into brain-dead patients, marking the latest advance toward addressing the nationwide organ shortage and developing a clinical protocol that would provide an alternative supply of organs for people with life-threatening heart disease. In 2024, Dr. Montgomery and his team of surgeons performed the world’s first combined implant of a mechanical heart pump and transplant of a kidney from a genetically modified pig, and later in the year, the first transplantation of a pig kidney with 10 gene edits.
In 2024, Stephanie H. Chang, MD, associate professor in the at NYU Grossman School of Medicine and the surgical director of the Lung Transplant Program at NYU Langone Transplant Institute, achieved a historic milestone by leading the nation’s first fully robotic lung transplant. Later that year, she further advanced medical innovation by heading the team that performed the world’s first double lung transplant using this robotic technology.
has spearheaded innovations that have not only transformed the training of our own medical students but also inspired educational reforms at other medical schools nationwide. In 2013, the school began offering an accelerated for select students, an initiative designed to ease the financial burden of medical school and launch medical careers one year earlier than traditional students. The program made NYU Langone the first nationally ranked academic medical center in the United States to enable graduates to pursue a career in either primary care or the medical specialty of their choice in three years.
In 2010, NYU Grossman School of Medicine introduced its Curriculum for the 21st Century (C21). This curriculum changes the historic approach of teaching by introducing medical students to specific areas of medicine, or “pillars,” on their very first day to foster student knowledge both through a study of the scientific underpinnings of a disease and, at the same time, through direct patient care—from the basic sciences to bedside application and back again. C21 allows every student to complete their graduation requirements in three years and pursue residency training anywhere in the country. Alternatively, students may elect to stay for an optional fourth year to pursue research or one of several dual degrees that combine a medical degree with a master’s degree.
Then in 2018—and through a groundswell of generosity from hundreds of alumni, NYU Langone trustees, and other scholarship supporters—the school once again made history. NYU Grossman School of Medicine became the first top-ranked medical school in the nation to provide to all new and current students, a bold strategy to reduce the staggering debt incurred by medical students due to the ever-rising cost of their education.
In 2019, NYU School of Medicine was renamed NYU Grossman School of Medicine in honor of the landmark educational achievements and visionary leadership of Robert I. Grossman, MD, who as dean and CEO from 2007 to 2025 vaulted the school to national renown. Today, one in six medical school applicants nationwide set their sights on NYU Grossman School of Medicine.
Also in 2019, NYU Langone expanded its medical student training when it launched , a joint venture between New York University and NYU Langone. The school, which also provides , is the only accelerated three-year MD program focused on primary care in New York State.
In 2024, a study by NYU Grossman School of Medicine researchers, published in Academic Medicine, found that the three-year graduates performed as well as or better than their peers across nearly all metrics. NYU Grossman School of Medicine’s success has inspired other institutions to adopt three-year medical degree programs. The school leads a consortium of more than 30 medical schools nationwide, funded by the Josiah Macy Jr. Foundation, to share best practices and expand the model.
NYU Langone Health is among the nation’s top-funded health systems for research, with $882 million in active awards from the National Institutes of Health (NIH) as of August 2025. NYU Grossman School of Medicine is the fastest-growing research enterprise among the country’s top 20 medical schools, distinguished for its productivity and impact. On a per-researcher basis, we hold more active NIH awards than any other peer institution.
Our community of more than 1,000 investigators drives some of the most ambitious and transformative research efforts in the nation. Year after year, we rank among the top three research-intensive medical schools in active NIH funding per investigator.
From aging and neurodegenerative disease to cancer, cardiology, and beyond, our investigators are advancing discoveries that redefine what is possible in medicine. With a strong track record of securing major NIH awards and translating discoveries into real-world impact, NYU Langone continues to set the standard for innovation and leadership in biomedical research.
Our campus transformation project is reshaping NYU Langone through construction, renovations, and expansions.
NYU Langone Health is committed to reducing our impact on the environment through a strategic sustainability program.
We aim to foster healthy behavior change and reduce risk factors for disease at the neighborhood level.
These assessments determine the potential impacts of NYU Langone Health projects on accessibility and delivery of healthcare services.
We release our quarterly or financial reports, encompassing the full financial scope of the enterprise.
Learn about the ways we are creating healthier communities in the New York metropolitan area.